The global economic downturn has made investors reconsider their commitments towards the deployment of capital into new-age firms
Silicon Valley Bank became the financier to tech stars by offering an array of products tailored to their needs, that few other institutions dared
Razorpay is offering domestic start-up clients to move their money into their Indian current accounts as FDI through the firm's partner banks
Investors are starting to realise that new-age companies are a completely different animal
RPSG Capital Ventures on Tuesday announced USD 2.5 million in an oral care brand to expand its consumer D2C portfolio. A part of the diversified RPSG Group, RPSG Capital Ventures is an early-stage consumer VC fund and the investment in the growing oral care segment is for the first time, an official said. Abhishek Goenka, head and chief investing officer, RPSG Capital Ventures, said, We are committed to supporting companies that use clean label innovation and customer centricity to create unique solutions that can address consumer problems at scale." RPSG Capital Ventures' decision to enter the oral-care segment through Perfora' brand is driven by a major market need, he said. Although poor oral health can cause massive challenges, it is still underpenetrated and underused due to lack of awareness and access to the right solutions, Goenka said. Jatin Bawa, co-founder of Perfora', said, We are building the brand with a vision to transform oral hygiene for Indian consumers. We are o
71% of founders of early-stage companies plan to raise venture debt this year
With late-stage funding rounds becoming tougher, they are focusing more on due diligence, profitability path, governance and early entry into companies at lower valuations
Despite this decline, 2022 marks the second-best year for PE/VC investments in India to date; dip largely due to smaller deal sizes amid stable volumes
Venture capital (VC) investments in Indian startups plunged over 38 per cent in 2022 as economic uncertainty and market volatility affected fundraising and investment activities, GlobalData said on Tuesday. In a statement, GlobalData said an analysis of its financial deals database reveals that "a total of 1,726 VC funding deals worth USD 20.9 billion were announced in India in 2022 compared to 1,715 deals worth USD 33.8 billion in 2021." "The ongoing economic uncertainty and market volatility continue to affect the fundraising and investment activities in India and subsequently VC investment in the country startups suffered a massive year-on-year 38.2 per cent decline in value terms during 2022," the data and analytics company said. Aurojyoti Bose, lead analyst at GlobalData, said India is a key Asia-Pacific market and stands just next to China in terms of VC funding deals by volume and value. It is also among the top four markets (the US, the UK, China and India) globally. India
Firm will invest in financial services, healthcare tech, enterprise software space
Leading global and domestic institutions and family offices, including HDFC Life and SIDBI, participated in the fund
Tredence is looking at Advent International to not only grow geographically but also support them in expanding into new verticals like healthcare, life inorganic sciences, and insurance
But does this mean that 2023 could be different, given the unutilised capital?
Company will use money to promote brands, increase offline distribution, and expand internationally
Markets regulator Sebi recently told RBI that some non-bank lenders were ever-greening loans by using alternative investment funds. But what exactly is this fund? Let's find out
Climate tech start-ups traditionally require longer gestation periods due to which the sector has not generated strong commercial returns recently
Inflation woes, recession fears, the rising cost of capital, and elevated levels of uncertainty driven by geopolitical tensions have weighed down the PE/VC activity in 2022
The top venture capitalist also predicted that at least 25 Indian unicorns will go for IPO in the next 3-5 years
Firm provides affordable diabetes care with a focus on people who don't have access to specialists
The second fund was launched in March 2021 with a base target corpus of $75 million and including a green shoe target of $100 million